Related references
Note: Only part of the references are listed.Nimotuzumab for pediatric diffuse intrinsic pontine gliomas
Maura Massimino et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances
Paola Angelini et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger et al.
NEURO-ONCOLOGY (2011)
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Ian F. Pollack et al.
NEURO-ONCOLOGY (2011)
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Prospective Collection of Tissue Samples at Autopsy in Children With Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
CANCER (2010)
A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma
Julia R. Sharp et al.
EUROPEAN JOURNAL OF CANCER (2010)
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
J. Russell Geyer et al.
EUROPEAN JOURNAL OF CANCER (2010)
RADIATION ASSOCIATED BRAINSTEM INJURY
Charles Mayo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
Sridharan Gururangan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
THE ROLE OF HYPOFRACTIONATION RADIOTHERAPY FOR DIFFUSE INTRINSIC BRAINSTEM GLIOMA IN CHILDREN: A PILOT STUDY
Geert O. R. J. Janssens et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors
Mark W. Kieran et al.
PEDIATRIC BLOOD & CANCER (2009)
Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: Results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy
Stephanie E. Combs et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: A pediatric brain tumor consortium study
Sridharan Gururangan et al.
CLINICAL CANCER RESEARCH (2008)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric brain tumor consortium study PBTC-012
Tobey J. MacDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma
Daphne A. Haas-Kogan et al.
NEURO-ONCOLOGY (2008)
Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: Final results of BSG 98 prospective trial
Didier Frappaz et al.
NEURO-ONCOLOGY (2008)
Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma
Nongnuch Sirachainan et al.
NEURO-ONCOLOGY (2008)
Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function
Thomas E. Merchant et al.
PEDIATRIC BLOOD & CANCER (2008)
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A children's oncology group phase II study
David N. Korones et al.
PEDIATRIC BLOOD & CANCER (2008)
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma - A children's oncology group study
Maryam Fouladi et al.
CANCER (2007)
Phase I study of everolimus in pediatric patients with refractory solid tumors
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: A Pediatric Brain Tumor Consortium Study
Mark W. Kieran et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report
Ian F. Pollack et al.
NEURO-ONCOLOGY (2007)
Diffuse brainstem glioma in children: critical review of clinical trials
D Hargrove et al.
LANCET ONCOLOGY (2006)
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas - Results of a French Society of Paediatric Oncology Phase II study
V Bernier-Chastagner et al.
CANCER (2005)
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study
NC Daw et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study
LS Lashford et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide
JEA Wolff et al.
BRITISH JOURNAL OF CANCER (2002)
What have we learnt from previous phase II trials to help in the management of childhood brain tumours?
P Chastagner et al.
EUROPEAN JOURNAL OF CANCER (2001)
Fractionated stereotactic conformal radiation therapy of brain stem gliomas:: outcome and prognostic factors
D Schulz-Ertner et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Share Paper
